AAP, AHA clarify ADHD cardiac risk statement
Doing an ECG first before kids get ADHD drugs is the preferred course of treatment, say AAP and AHA.
Following confusion over a statement released in April 2008 about the appropriate use of an electrocardiogram (ECG) in the cardiovascular evaluation and monitoring of children receiving medication for attention deficit hyperactivity disorder (ADHD), both the American Academy of Pediatrics (AAP) and the American Heart Association (AHA) have issued a joint advisory to clarify the recommendations. Acquiring an ECG prior to beginning treatment for ADHD is not mandatory, but is reasonable for a physician to consider as part of the evaluation of children being considered for stimulant therapy, say the groups. Treatment should not be withheld, however, because an ECG is not performed. The remainder of the clarifications are also available online.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
Socioeconomic Disparities Persisted Alongside Improving Vaccination Rates In US Over 11-Year Period
April 16th 2024Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.
